Table 2.
Factor | Function | Ref |
---|---|---|
WNK/SPAK | Phosphorylates KCC2 extracellular domain and inhibit KCC2 | 58 |
Brain-type creatine kinase | Directly binds to KCC2 and Activates KCC2 | 59 |
PACSIN1 | A neuronal endocytic regulatory protein that inhibits KCC2 expression | 60 |
Gephyrin | Anchor protein to stabilize KCC2 expression | 61 |
GABAB Receptor | Directly bind to KCC2 and inhibit its expression | 62 |
BDNF | Down-regulates KCC2 expression by CREB phosphorylation | 63 |
MECP2 | Inhibit KCC2 expression by binding KCC2 promotor | 33 |
FLT3 | Receptor tyrosine kinase that Inhibits KCC2 expression via AKT signaling | 7 |
GSK3β | Inhibits KCC2 expression by inactivating KCC2 promoter (activate histone deacetylase and/or IL1β-REST signaling) |
64 |
SIRT1 | Activate KCC2 expression by inhibiting REST gene expression | 65 |
TRPV1 | Activate KCC2 expression | 7 |
Estradiol | Down-regulates KCC2 expression in male mouse | 66 |
Oxytocin | Activates KCC2 by inhibiting GSK3β | 42 |
miR-137 | Directly down-regulates KCC2 expression | 67 |
CLP257 | KCC2 activator, increase its function by KCC2 phosphorylation | 68 |
CLP290 | KCC2 activator, pro-drug of CLP257 | 68 |
Bisphenol A | KCC2 inhibitor by inactivating KCC2 promoter (inhibit histone acetyltransferase) |
69 |
Furosemide | KCC2 inhibitor. Also inhibit NKCC1 | 70 |
bumetanide | KCC2 inhibitor. Also inhibit NKCC1 | 70 |
Kamikihito | Activates KCC2 by upregulating oxytocin expression | 15 |